SCHEMBL27467095

SCHEMBL27467095

Nc1cccc(C(=O)Nc2cc(F)cc(C(F)(F)F)c2)c1Cc1ccncc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P2RX1 P51575 8/20 0.54
▸ KDR P35968 5/20 0.52
▸ FLT1 P17948 2/20 0.50
▸ ABL1 P00519 1/20 0.50
▸ EGFR P00533 1/20 0.50
▸ CSF1R P07333 1/20 0.50
▸ PDGFRB P09619 1/20 0.50
▸ KIT P10721 1/20 0.50
▸ FLT4 P35916 1/20 0.50
▸ P2RX7 Q99572 3/20 0.49
▸ PTGS1 P23219 2/20 0.49
▸ P2RX4 Q99571 2/20 0.46
▸ TMPRSS4 Q9NRS4 2/20 0.46
▸ RXFP1 Q9HBX9 1/20 0.45
▸ XPO1 O14980 1/20 0.44
▸ TRPA1 O75762 1/20 0.43
▸ GAA P10253 1/20 0.43
▸ AHR P35869 1/20 0.43
▸ HSD17B10 Q99714 1/20 0.43
▸ RIPK1 Q13546 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27466657 0.89 PTGS1 (0.64) P2RX1KDRFLT1ABL1EGFR
SCHEMBL27484180 0.82 GRM4 (0.50) KDRFLT1ABL1EGFRCSF1R
SCHEMBL27548630 0.80 PTGS1 (0.63) P2RX1KDRFLT1ABL1EGFR
SCHEMBL27486254 0.79 SMN1; SMN2 (0.53) KDR
SCHEMBL27591129 0.79 MAPT (0.49) KDRFLT1ABL1EGFRCSF1R
SCHEMBL5666012 0.79 P2RX1 (0.84) P2RX1P2RX7PTGS1P2RX4TMPRSS4
SCHEMBL27483851 0.78 PTGS1 (0.60) P2RX1KDRFLT1ABL1EGFR
SCHEMBL27468045 0.78 KDR (0.44) KDRFLT1ABL1EGFRCSF1R
SCHEMBL4980207 0.78 KDR (0.77) KDRFLT1ABL1EGFRCSF1R
SCHEMBL27467102 0.77 SMN1; SMN2 (0.54) KDRGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN claimed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN claimed
CN-1152014-C N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors ��˹��ŵ�� 2004-06-02 — — CN disclosed
CN-1331680-A N-aryl (thio) anthranilic acid amide derivatives, their prepn. and their use as VEGF receptor tyrosine kinase inhibitors NOVARTIS AG (CH) 2002-01-16 — — CN disclosed
Send feedback